drugset / Trial / NCT01499368
A Multi-center, Randomized, Double-blind Phase III Clinical Trial to Assess and Compare to the Efficacy and Safety of Lafutidine, Famotidine and Omeprazole-referenced in Korean Erosive Esophagitis Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To evaluate the healing rate and safety of Lafutidine in erosive esophagitis
Timeline
- Start
- 2011-11
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Famotidine | Other / unclassified | 40 mg | — |
| Subject | Lafutidine | Small molecule | 20 mg | — |
| Subject | Omeprazole | Other / unclassified | 20 mg | — |